SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-421466"
 

Search: onr:"swepub:oai:DiVA.org:uu-421466" > Effect of alteplase...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair, Grant (author)
von Kummer, Rüdiger (author)
Morris, Zoe (author)
show more...
von Heijne, Anders (author)
Karolinska Institutet
Bradey, Nick (author)
Cala, Lesley (author)
Peeters, André (author)
Farrall, Andrew J (author)
Adami, Alessandro (author)
Potter, Gillian (author)
Cohen, Geoff (author)
Sandercock, Peter A G (author)
Lindley, Richard I (author)
Wardlaw, Joanna M (author)
Lundström, Erik, Docent, 1964- (contributor)
Uppsala universitet,Institutionen för neurovetenskap
show less...
 (creator_code:org_t)
2016
2016
English.
In: Neurology. - 0028-3878 .- 1526-632X. ; 86:2, s. 118-25
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • OBJECTIVE: To investigate whether the location and extent of the CT hyperdense artery sign (HAS) at presentation affects response to IV alteplase in the randomized controlled Third International Stroke Trial (IST-3).METHODS: All prerandomization and follow-up (24-48 hours) CT brain scans in IST-3 were assessed for HAS presence, location, and extent by masked raters. We assessed whether HAS grew, persisted, shrank, or disappeared at follow-up, the association with 6-month functional outcome, and effect of alteplase. IST-3 is registered (ISRCTN25765518).RESULTS: HAS presence (vs absence) independently predicted poor 6-month outcome (increased Oxford Handicap Scale [OHS]) on adjusted ordinal regression analysis (odds ratio [OR] 0.66, p < 0.001). Outcome was worse in patients with more (vs less) extensive HAS (OR 0.61, p = 0.027) but not in proximal (vs distal) HAS (p = 0.420). Increasing age was associated with more HAS growth at follow-up (OR 1.01, p = 0.013). Treatment with alteplase increased HAS shrinkage/disappearance at follow-up (OR 0.77, p = 0.006). There was no significant difference in HAS shrinkage with alteplase in proximal (vs distal) or more (vs less) extensive HAS (p = 0.516 and p = 0.580, respectively). There was no interaction between presence vs absence of HAS and benefit of alteplase on 6-month OHS (p = 0.167).CONCLUSIONS: IV alteplase promotes measurable reduction in HAS regardless of HAS location or extent. Alteplase increased independence at 6 months in patients with and without HAS.CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that for patients within 6 hours of ischemic stroke with a CT hyperdense artery sign, IV alteplase reduced intra-arterial hyperdense thrombus.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Neurology (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view